Evidence map›Paper›PMID 36091190›Full record

ArticleRSC advances2022

l-Asparagine-EDTA-amide silica-coated MNPs: a highly efficient and nano-ordered multifunctional core-shell organocatalyst for green synthesis of 3,4-dihydropyrimidin-2(1

Negin Rostami, Mohammad G Dekamin, Ehsan Valiey, Hamidreza FaniMoghadam

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Magnetic BiFeOScientific reports · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. FeScientific reports · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Negin RostamiPharmaceutical and Biologically-Active Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir +98-21-7730 21584 +98-21-77 240 284.
Mohammad G DekaminPharmaceutical and Biologically-Active Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir +98-21-7730 21584 +98-21-77 240 284.ORCID https://orcid.org/0000-0002-7018-7363
Ehsan ValieyPharmaceutical and Biologically-Active Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir +98-21-7730 21584 +98-21-77 240 284.ORCID https://orcid.org/0000-0002-8332-5112
Hamidreza FaniMoghadamPharmaceutical and Biologically-Active Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir +98-21-7730 21584 +98-21-77 240 284.
Iran University of Science and Technology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, new l-asparagine grafted on 3-aminopropyl-modified Fe

Identifiers

PMID36091190
PMCPMC9386691
OpenAlexW4292486506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.